MAIA Biotechnology Inc (MAIA)
3.20
+0.02
(+0.63%)
USD |
NYAM |
Jun 25, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Research and Development Expense (TTM): 11.24M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.24M |
| December 31, 2023 | 11.11M |
| September 30, 2023 | 9.788M |
| June 30, 2023 | 9.532M |
| March 31, 2023 | 9.052M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.904M |
| September 30, 2022 | 7.975M |
| June 30, 2022 | 6.714M |
| March 31, 2022 | 5.238M |
| December 31, 2021 | 3.453M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.453M
Minimum
Dec 2021
11.24M
Maximum
Mar 2024
8.301M
Average
8.978M
Median
Research and Development Expense (TTM) Benchmarks
| Ampio Pharmaceuticals Inc | 2.439M |
| 180 Life Sciences Corp | 2.525M |
| Flora Growth Corp | 0.093M |
| Invivyd Inc | 162.62M |
| Tivic Health Systems Inc | 1.421M |